The Food and Drug Administration is wrestling with how to decide on booster doses of the single-shot Johnson & Johnson COVID-19 vaccine.
Other manufacturers want to offer boosters six months after primary vaccination.
But J&J proposed a range of times, from two months to six months.
In a review posted Wednesday, FDA scientists didn't reach a firm conclusion, citing shortcomings with J&J's data.
On Thursday and Friday, an FDA advisory panel will recommend whether to back boosters of both the J&J and Moderna vaccines.
An extra dose of Pfizer's vaccine already is available to certain Americans.
(Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.)
Â
